Description
Sotorasib (AMG-510) is an orally active and selective covalent inhibitor of KRAS G12C. Sotorasib binds to the GDP state of the inactive conformation of KRAS G12C and inhibits KRAS and its downstream signaling. Sotorasib exhibits inhibitory activity against KRAS G12C mutant tumors.
Molecular Formula
C30H30F2N6O3
Smiles
CC(C)C1NCCC(C)C1-N1C2NC(C(F)CC2C(NC1=O)N1CCN(C[C@@H]1C)C(=O)C=C)-C1C(O)CCCC1F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
H2O: 33.33 mg/mL (59.46 mM), when pH is adjusted to 11 with NaOH. Sonication is recommended.DMSO: 60 mg/mL (107.03 mM), Sonication is recommended.
Relative Density
1.36 (Predicted)